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Abstract
Microsporidial infections may be asymptomatic in immunocompetent hosts, but can be severe and disseminated in HIV/AIDS 
patients, children, the elderly, or in immunocompromised individuals, including those with primary or medically-induced 
immunodeficiencies. 209 faecal samples were collected from 80 clinical patients, with or without abdominal symptoms, and 
tested for the presence of the parasites. Microsporidia were found in 10 of the 80 patients (12.5%) using trichrom staining of 
faecal smears and/or PCR. Encephalitozoon intestinalis and 1 unidentified species were identified in 2 of the 32 children with 
primary immunodeficiencies (6%), presenting with diarrhoea, including one co-infection with Cryptosporidium meleagridis. 
In the group of patients with medically-induced immunosuppression (transplant recipients), 8 of the 48 patients (17%) were 
tested positive for microsporidia. Thus, these pathogens should be taken into account when the other etiological agents 
cannot be found in diarrheic patients with PIDs or undergoing immunosuppressive treatment before or after transplantation. 
This article presents the results of the first epidemiological study on the occurrence and prevalence of microsporidia in 
patients with primary and secondary immunodeficiency in Poland.
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INTRODUCTION
Microsporidia are a group of intracellular parasites which 
have attracted the interest of parasitologists for over 100 
years. The first species, Nosema bombycis, was discovered 
in the middle of the 19th century as the cause of silkworm 
disease (i.e., pepper disease, pébrine disease), which nearly 
destroyed the silkworm industry in Southern Europe [1, 2]. 
Since then, more than 1,400 microsporidian species have been 
described in both invertebrate and vertebrate hosts. Only 7 
genera and 15 species of microsporidia have been associated 
with human infections [3, 4, 5]. The first report on human 
microsporidia infection was in 1959 and described the case of 
a 9-year-old Japanese boy who presented with disseminated 
microsporidiosis associated with fever, headache, vomiting, 
and spastic convulsions [6]. Interest in this group of parasites 
started with the development of the AIDS pandemia around 
the world in 1980’s. In 1985, a new species Enterocytozoon 
bieneusi was found in an HIV-infected patient [7]. Since then, 
species of microsporidia have been recognized worldwide 
as etiologic agents of opportunistic infections. The clinical 
course of microsporidiosis depends on the immune status 
of the patient and the site of infection. The groups at risk 
constitute people with HIV/AIDS, organ transplant recipients 
being treated with immunosuppressive drugs, travellers, 
children and the elderly [8, 9, 10, 11, 12, 13]. Microsporidiosis 
may present as persistent or chronic diarrhea (Enterocytozoon 
bieneusi, Encephalitozoon intestinalis infection), urinary, 
pulmonary or disseminate infections that include sinusitis, 
encephalitis, tracheobronchitis, interstitial nephritis, hepatitis 
or myositis (E. intestinalis and other Encephalitozoon species). 
Increasingly, ocular microsporidiosis and microsporidial 
stromal keratitis are identified, particularly in contact lens 
users [2, 14].
Two species, E.  bieneusi and E.  intestinalis are 
responsible for the majority of the gastrointestinal and 
biliary tract infections in humans. They may cause severe 
persistent diarrhea with malabsorption and weight loss, 
but asymptomatic infections have also been reported in 
immunocompetent persons [15, 16]. Routine diagnosis is 
based on light microscopy observation of chromotrope-
based stained faecal smears, or another optically-brightening 
agent such as Uvitex 2B or Fungifluor [17, 18]. However, the 
differentiation of the microsporidian species is not solely 
based on spore observation and measurements; thus, PCR-
based methods are recommended for this task, due to their 
sensitivity and specificity. Serological assays are not useful 
in diagnosis, however, they may be used for epidemiologic 
surveys [18, 19, 20].
Human microsporidiosis occurs worldwide, but data on 
the prevalence and geographic distribution of microsporidial 
infections are still incomplete and very diverse due to the use 
of different diagnostic methods and host subgroups [1, 5, 21]. 
Although many papers report microsporidial infection in 
HIV/AIDS patients, the epidemiological studies in other risk 
groups are still scarce [14, 16, 21]. In Poland, detection of 
microsporidia is not routinely performed in clinical practice, 
and only single cases of human microsporidiosis have been 
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reported to date by scientists [22]. To our knowledge, no 
epidemiological studies have been completed in the area of 
Poland to date.
This paper presents the results of a study on the occurrence 
of intestinal microsporidia in 2 groups of patients: children 
with primary immunodeficiencies (PIDs) and clinical 
patients with medically-induced immunosuppression.
MATERIALS AND METHOD
Stool specimens. During a 7-year period (2002–2008), 
209 samples were collected from 80 patients in 3 hospitals 
in Poland: the Children’s Memorial Health Institute (CMHI), 
Institute of Haematology and Transfusion Medicine, both in 
Warsaw, and the Institute of Transplantology at the Medical 
University of Warsaw. Patients were divided into 2 groups on 
the basis of their age and immunological status:
Group 1. consisted of 31 children and 1 young man, who 
were patients from the CMHI. They presented impaired 
immunity due to various primary immunodeficiencies 
(PIDs as CD40L deficiency= hyper IgM syndrome; 
SCID, Omenn syndrome; Nijmegen breakage syndrome), 
and/or immunosuppressive treatment before or after organ 
transplantation (bone marrow or liver). Patients in this group 
presented with diarrhea or showed features of sclerosing 
cholangitis and hepatitis (Tab. 1).
Group 2. consisted of 48 adult patients subjected to medical 
immunosuppression before or after organ transplantation 
(kidney, liver or bone marrow). These patients rarely 
manifested intestinal disorders (Tab. 1). Faecal samples were 
collected from all patients on 2, 3 or more occasions, and 
stored at +4 °C. The samples had been previously checked 
for Cryptosporidium and Giardia (oo)cysts by means of an 
immunofluorescent assay (IFA) and nested-PCR [24, 25].
Staining of faecal smears. Faecal smears were made from 
fresh stool specimens, air dried, fixed in methanol and 
stained with modified Weber’s chromotrope-based staining- 
trichrom staining [26] (Chromotrope 2R Para-Pak Trichrome 
Stain, Meridian Diagnostics, Cincinnati, OH, USA). Smears 
were examined under oil immersion (x1,000 magnification). 
Pinkish-red oval objects measuring <2 μm in length, with 
a characteristic posterior vacuole and belt-like stripe in the 
middle, were identified as microsporidian spores.
Molecular methods. For the DNA extraction, stool 
specimens were first concentrated by modified Sheather’s 
sucrose flotation [27]. DNA extraction and purification 
were carried out using QIAamp DNA Stool Mini Kit (Qiagen). 
Three sets of primers were used for PCR amplification.
Initially, to screen for the range of human-
infecting microsporidial species including E.  cuniculi, 
E. hellem, E. intestinalis and E. bieneusi,  the ‘general’ 
primers by Raynaud et. al. [28] were used to amplify 
a 1,200 bp conserved region of the small-subunit (SSU) 
rRNA gene. These were: forward primer C1modyf 
(5’-CACCAGGTTGATTCTGCCTG-3’) and reverse primer 
C2modyf (5’-GACGGGCGGTGTGTACAAAG-3’).
Species-specific primers SINTF 
(5’-TATGAGAAGTGAGTTTTTTTC-3’) and SINTR 
(5’-CCGTCCTCGTTCTCCTGCCCG-3’) were then 
used to amplify a region of 545 bp from the SSU-rDNA 
of  E.  intestinalis [29]. Species-specific primers EBIEF 
(5’-GAAACTTGTCCACTCCTTACG-3’) and EBIER 
(5’-CCATGCACCACTCCTGCCATT-3’) were used to 
amplify a 607 bp fragment of the SSU-rDNA of E. bieneusi [30].
PCR conditions for C1modyf / C2modyf primers were: 
an initial denaturation at 94 °C for 5 min.; then 35 cycles as 
follows: denaturation at 94 °C for 1 min, annealing at 56 °C 
for 1 min and elongation at 72 °C for 1 min; with 5 min of 
final elongation at 72 °C.
For 2 sets of species-specific primers, the PCR conditions 
were: an initial denaturation at 94 °C for 5 min.; then 35 cycles 
as follows: denaturation at 94 °C for 30 sec, annealing at 58 °C 
for 30 sec and elongation at 72 °C for 90 sec, with 5 min of 
final elongation at 72 °C.
PCR reactions were conducted in a volume of 20 µl reaction 
mixture, in 2 repetitions for 3 and 5 µm of target DNA. 
Reactions were performed in a final volume of 20 μl and 
contained 0.33 mM dNTPs (Eurobio, Lille, France), 2 mM 
MgCl2, 1  ×  PCR buffer, 1 U Taq polymerase (Fermentas), 
1 μM of each primer and 3 or 5 μl of extracted DNA. Two 
sets of controls, positive and negative, were incorporated 
in each PCR turn. Amplicons were visualized with Midori 
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Table 1.  Characteristics of intestinal microsporidial infections in 
immunodeficient and immunosuppressed patients 
No. and 
origin 
of 
samples
Gen-
der
Age
(year)
Immuno-
logical 
status
Type & 
status
of trans-
plant
Chr_2R
results
PCR
results
Diar-
rhea
Species
9/02 M  6
PID,
(Hyper 
IgM)
bone 
marrow
ND + yes
Entero­
cytozoon/
Encepha­
litozoon
36/07 M 29
PID,
(Hyper 
IgM)
nd ND + no
 E. 
intestinalis
04/tra F 50 IS
kidney / 
after
MS 
spores
neg no
not deter-
mined
07/tra M 54 IS
liver/ 
after
MS 
spores
neg no
not deter-
mined
51/
hem
M 34 IS
bone 
marrow 
/ before
MS 
spores
neg no
not deter-
mined
52/
hem
F 44 MD
bone 
marrow 
/ before
MS 
spores
neg no
not deter-
mined
53/
hem
M 28 IS
bone 
marrow 
/ before
MS 
spores
neg no
not deter-
mined
54/
hem
M 21 IS
bone 
marrow 
/ before
MS 
spores
+ yes
E. intesti­
nalis
55/
hem
M 25 IS
bone 
marrow 
/ after
neg + no
E. intesti­
nalis
56/
hem
M 39 IS
bone 
marrow 
/ before
MS 
spores
neg no
not deter-
mined
Chr_2R – trichrom stainIS – immunosuppression 
MD – moderate immunodeficiency
MS spores – presence of spores on  slides
ND – not done
PID – primary immunodeficiency
No. 04/tra and 07/tra – samples from patients of the Institute of Transplantology, Medical 
University, Warsaw, Poland
No. 51–56 with part –‘hem’ are samples from patients of the Institute of Haematology and 
Transfusion Medicine, Warsaw, Poland 
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Green stain (Nippon Genetics Europe GmbH) following 
electrophoresis in 1.5% agarose gels.
RESULTS
Prevalence of microsporidial infections in patients. Ten 
microsporidial  infections were detected in 80 patients 
(12.5%), including 6 positive only through to microscopical 
examination of faecal smears and/or 4 positive by PCR (Tab. 1).
In the first group of patients, 2 of the 32 individuals with 
PIDs (1 child and 1 young man) were identified as positive 
(6.3%) on the basis of positive results of PCR:
Patient No. 36/07 – infection with Enterocytozoon/ 
Encephalitozoon spp. was identified using ‘general’ primers 
C1modyf/ C2 modyf, and the microsporidian species was 
determined as E. intestinalis using species-specific primers 
SINTF/SINTR.
Patient No. 9/02 – diagnosed as infected with 
Enterocytozoon/ Encephalitozoon spp. using ‘general’ primers 
C1modyf/ C2 modyf. No positive results were obtained for 
E. bieneusi-specific EBIEF/EBIER primers.
In this group of patients, trichrom staining of faecal smears 
was only carried out for 10 patients hospitalized during 
2007–2008. All samples examined by light microscopy were 
negative.
In the second group of patients, with medically-induced 
immunosuppression, all samples were examined by 
2 methods, trichrom staining and PCR. Eight out of 48 
(16.7%) patients were positive for microsporidia on the basis 
of trichrom staining (7 cases) and/or PCR (2 cases) (Tab. 1). 
In patient No. 54 – microsporidian infection / hem was 
confirmed on the basis of 2 methods, light microscopy and 
PCR (Tab. 1).
All smears positive by light microscopy were positively 
verified in the laboratory of the Department of Environmental 
Health Sciences, Johns Hopkins Bloomberg School of Public 
Health, Baltimore, Maryland, USA.
Two patients were diagnosed as infected with E. intestinalis 
using the species-specific primers SINTF/SINTR (Tab. 1). No 
positive PCR results were obtained for ‘general’ C1modyf/
C2modyf or E. bieneusi-specific EBIEF/EBIER primers sets 
in this group of patients.
Co-infection with E. intestinalis and Cryptosporidium 
meleagridis. In the first group of patients with PIDs, 
E. intestinalis infection was detected in patient No. 9/02, 
who had CD40L deficiency (hyper IgM syndrome) and was 
previously documented as the first case of C. meleagridis 
infection in Poland [24, 25]. Cryptosporidium meleagridis 
infection in this patient lasted for up to 29 months, despite 
applied treatment [24]. Following his third and the first 
successful bone marrow transplantation (HSCT), the patient 
recovered and became free of both Cryptosporidium and 
microsporidian parasites.
Symptomatic and asymptomatic infections. Diarrhea 
and/or another abdominal symptoms were reported by 25 
of the 80 patients involved in the study, including 21 patients 
with PIDs from the first group and 4 patients with medically-
induced immunosuppression from the second group (before 
or after organ transplantation). Only 2 patients in whom 
E. intestinalis infection was identified, presented various 
abdominal symptoms. The other microsporidian infections 
(n=8) detected in these patients remained asymptomatic.
DISCUSSION
The main aim of the presented paper was to carry out the 
first epidemiological study in Poland on the occurrence 
of microsporidia in 2 groups of patients at risk of 
microsporidiosis, with impaired immune systems (PIDs 
and transplant patients). By applying 2 methods for the 
detection of intestinal infections, the overall prevalence of 
microsporidia, mainly E. intestinalis, was determined as 
12.5%. Prevalence was higher in the group of transplant 
recipients in comparison to children with PIDs (17% and 6%, 
respectively). These values are very similar to the prevalence 
found in patients with chronic diarrhea, which was in the 
range of 6 – 17% for children and elderly people [12, 31, 32, 33, 
34]. In other studies, when the seroprevalence was determined, 
the values ranged from 1.3% – 8% in immunocompetent 
persons, such as blood donors and animals breeders [20]. 
Prevalence of microsporidial infections in HIV/AIDS patients 
may be higher and varies from approx. 5% – 50%, with overall 
prevalence of about 15% [4, 10, 35, 36]. In Poland, detection 
of microsporidia is not routinely carried out in clinical 
diagnostics, and only single cases of infection in humans have 
been reported to date [22, Bednarska – GenBank, Accession 
No. JN107808].
Recently,  E. intestinalis  infections were identified in 
2 lemur species from the Zoological Garden in Poznań, 
Poland, confirming the existence of a zoonotic reservoir of the 
pathogens [37]. This study presents the first epidemiological 
data on these important opportunistic pathogens in 
immunocompromised, non-HIV/AIDS patients. To the best 
of our knowledge, this is also the first report on microsporidia 
infections in patients with PIDs, confirmed by PCR technique. 
In an earlier study, Aoun et al. [38] identified microsporidia 
in 2 boys with PIDs (including 1 with hyper IgM syndrome, 
as in the presented study) by microscopical observation of 
Chromotrop-stained faecal smears.
Among non-HIV/AIDS patients and immunosuppressed 
individuals, such as organ transplant recipients, children, and 
patients with chronic diseases, microsporidiosis is manifested 
rather as self-limited diarrhea or can be asymptomatic 
[16, 21, 39]. In the presented study, only 2 patients manifested 
intestinal disorders, including 1 child with CD40L deficiency 
(hyper IgM syndrome) and long-lasting C. meleagridis 
infection, that may have been responsible for the diarrhea 
[24, 25]. The second symptomatic patient was characterized 
by a relatively high intensity of infection, confirmed by 
positive results from 2 detection methods. Interestingly, 
recently, a study showing predominance of asymptomatic 
infections with different species/strains of Encephalitozoon 
and E. bieneusi was published on the basis of epidemiological 
studies in a healthy Czech population [16].
In the presented study, species-specific PCR revealed only 
1 microsporidian species in 3 patients positive by PCR– 
E. intestinalis. However, the species of microsporidia involved 
in the 7 cases identified only on the basis of microscopical 
observation of faecal smears or ‘general’ primers could not 
be determined; therefore, infections with E. bieneusi cannot 
be excluded. In developing countries, E. bieneusi prevalence 
rates for HIV/AIDS patients with diarrhea are between 2.5% 
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– 51% [16], and < 5% for patients without diarrhea have 
been reported [40]. For comparison, Encephalitozoon sp. 
infections are usually rarer, reaching a maximum of 10% 
[41]. In Poland, only recently, the first case of E. bieneusi 
infection in a transplant patient was identified [22]; therefore 
the higher occurrence of Encephalitozoon is not surprising.
Microsporidia were more common in the current study in 
the group of transplant recipients. There are less than 100 
cases of microsporidiosis reported in these types of patients 
worldwide, and microsporidian species were identified only 
in about 55% of these cases [9, 42, 43, 44]; the majority of 
the infections were diagnosed as E. bieneusi infections, and 
associated with intestinal disorders. Encephalitozoon spp. 
were rarely detected (about 10%) and the majority of these 
cases were found in kidney transplant recipients [9]. In these 
patients, disseminated but asymptomatic (without diarrhea) 
infections were common. Interestingly, in the majority of 
asymptomatic microsporidial infections, the species of 
parasite was not determined.
Presented above are the results of the first epidemiological 
study in Poland on microsporidia prevalence in patients 
with primary or secondary immunodeficiencies. The 
occurrence of microsporidia at the level of 12% suggests 
that these pathogens should be taken into account when other 
etiological agents cannot be found in diarrheic patients with 
PIDs, or those undergoing immunosuppressive treatment 
before or after transplantation. Additionally, asymptomatic 
but quite common infections of microsporidia may constitute 
a health risk factor in cases of advanced immune system 
impairment, i.e. due to co-infection in PIDs or medically-
induced.
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